Condensed Consolidated Statements of Stockholders' Equity - USD ($) shares in Thousands, $ in Thousands	Total	Class A and Class B Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022		683,202
Beginning balance at Dec. 31, 2022	$ 3,281,654	$ 7	$ 5,407,724	$ (11,419)	$ (2,114,658)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Release of restricted stock units and issuance of restricted stock awards, net (in shares)		2,775
Shares repurchased for tax withholdings on release of restricted stock units and restricted stock awards	(91,508)		(91,508)
Issuance of common stock for cash upon exercise of stock options, net (in shares)		950
Issuance of common stock for cash upon exercise of stock options, net	2,400		2,400
Repurchases of Class A common stock (in shares)		(2,770)
Repurchases of Class A common stock	(71,637)		(71,637)
Share-based compensation	143,122		143,122
Other comprehensive income (loss)	4,287			4,287
Net loss	(208,579)				(208,579)
Ending balance (in shares) at Mar. 31, 2023		684,157
Ending balance at Mar. 31, 2023	3,059,739	$ 7	5,390,101	(7,132)	(2,323,237)
Beginning balance (in shares) at Dec. 31, 2023		678,018
Beginning balance at Dec. 31, 2023	3,090,680	$ 7	5,241,954	(1,013)	(2,150,268)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Release of restricted stock units and issuance of restricted stock awards, net (in shares)		3,179
Shares repurchased for tax withholdings on release of restricted stock units and restricted stock awards	$ (99,708)		(99,708)
Issuance of common stock for cash upon exercise of stock options, net (in shares)	1,383	1,384
Issuance of common stock for cash upon exercise of stock options, net	$ 16,811		16,811
Share-based compensation	162,473		162,473
Other comprehensive income (loss)	(1,602)			(1,602)
Net loss	(24,812)				(24,812)
Ending balance (in shares) at Mar. 31, 2024		682,581
Ending balance at Mar. 31, 2024	$ 3,143,842	$ 7	$ 5,321,530	$ (2,615)	$ (2,175,080)